← FDA Drug Approvals (Drugs@FDA)
OXALIPLATIN
NDA · New Drug Application · Sponsor: TEVA PHARMS · Approved 2009-08-07
Drug application
- FDA Application #
NDA022160- Application type
- New Drug Application
- Brand name
- OXALIPLATIN
- Generic name
- Oxaliplatin
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS
- First approval
- 2009-08-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown